News Researchers start trial on AZ WEE1 drug in head and neck can... Phase 1 trial investigates use before and after surgery
News Future uncertain for Innate and BMS' troubled lirilumab Doubts over future of cancer immunotherapy
News NICE okays CDF funding for BMS' Opdivo in head and neck canc... Cancer Drugs Fund will reimburse Opdivo for 2 years
News BMS' Opdivo approved in head and neck cancer BMS hopes survival data will give advantage over rival.
News NICE rejects head and neck cancer drug once again NICE rejects German Merck's Erbitux, unsure of effectiveness.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
